Good Day BIO Newsletter Archive | September 21, 2023
Price controls are already hurting drug R&D, especially for rare disease, BIO’s Vice Chair John Crowley told Congress yesterday. Meanwhile, in New York, BIO’s SVP Phyllis Arthur spoke on a panel during the UN General Assembly about what we need to do to get ready for the next pandemic. (653 words,…